Highlights
NASDAQ: EGRX       Eagle Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
75.01   +1.12 (1.52%)  73.637 - 75.94  282,800

Overview

 
Avg Volume (4 weeks):470,363
4 Weeks Range:72.07 - 97.15
4 Weeks Price Volatility (%):
11.72%
52 Weeks Range:34.20 - 97.15
52 Weeks Price Volatility (%):
64.83%
Average Price Target: 65.00
Price Target Upside/Downside: -10.01

Headlines



No recent Headlines for this stock.


Business Background

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The Company's product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka. Its advanced candidates include EP-3101 (bendamustine Resistance Temperature Detectors (RTD)) (EP-3101), EP-4104 (dantrolene sodium for exertional heat stroke (EHS)) (EP-4104), EGL-4104-C-1702 (dantrolene sodium for drug induced hyperthermia), EP-5101 (pemetrexed) (EP-5101) and EGL-5385-C-1701 (fulvestrant). Its product portfolio focuses on oncology, critical care and orphan diseases. Bendamustine is an alkylating agent approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL), that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

  Be the first to like this.
 


 

3700  3395  893  405 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 JNS 14.17-0.08 
 BAC 23.24-0.01 
 DCTH 0.020.00 
 SPY 241.71-0.05 
 XLF 23.61-0.01 
 VXX 13.46-0.24 
 SIRI 5.29+0.17 
 XLK 56.38-0.03 
 AVP 3.41-0.14 
 GDX 22.94+0.23 
Partners & Brokers